Thermal and Behavioral Properties of the Biofield Energy Healing Treated Sodium Selenate

What is it about?

The objective of the current study was to investigate the impact of The Trivedi Effect® - Energy of Consciousness Healing Treatment (Biofield Energy Healing treatment) on physical, structural, thermal, and behavioral properties of sodium selenate using PXRD, PSD, FT-IR, UV-vis, TGA, and DSC analysis.

Featured Image

Why is it important?

The current analysis revealed that The Trivedi Effect® – Energy of Consciousness Healing Treatment (Biofield Energy Healing Treatment) displayed the significant impact on the physicochemical and thermal properties of sodium selenate. The PXRD analysis showed the remarkable alteration of the crystallite size of the treated sample from -49.99% to 50.01% compared with the control sample. Overall, the average crystallite size of the treated sodium selenate was decreased by 0.72% compared with the control sample. This result indicated that the crystal morphology of the treated sodium selenate was changed from the control sample and The Trivedi Effect® – Biofield Energy Healing might lead to a new polymorphic form of sodium selenate. The particle size of the Biofield Energy Treated sample at d10, d50, and d90 values were significantly decreased by 3.71%, 6.72%, and 26.17%, respectively compared with the control sample. Additionally, the surface area of the treated sample was increased by 6% from the control sample. TGA analysis revealed that the total weight loss of the Biofield Energy Treated sample was diminished by 4.93% compared with the control sample. The DSC analysis revealed that the treated sample (95.10°C) had higher vaporization temperature than the control sample (94.80°C). The latent heat of vaporization was increased significantly in the Biofield Energy Treated sample by 14.68% compared to the control sample. Briefly, the Biofield Energy Treated sodium selenate might be a new polymorphic form (i.e. enantiotropic) of sodium selenate having reduced crystallite and particle size and increased surface area. Thus, The Trivedi Effect® treated sodium selenate could be more soluble, bioavailable, and thermally stable than the control sample. Hence, treated sodium selenate would be very useful to design better nutraceutical and/or pharmaceutical formulations that might offer better therapeutic response against various diseases such as diabetes mellitus, allergies, and septic shock; stress-related disorders like sleep disorder, insomnia, anxiety, depression, Attention Deficit Disorder (ADD), Attention Deficit Hyperactive Disorder (ADHD), mental restlessness (mind chattering), brain frog, low libido, impotency, lack of motivation, mood swings, fear of the future, confusion, migraines, headaches, forgetfulness, overwhelm, loneliness, worthlessness, indecisiveness, frustration, irritability, chronic fatigue, obsessive/compulsive behavior and panic attacks; inflammatory diseases and immunological disorders like Lupus, Systemic Lupus Erythematosus, Hashimoto Thyroiditis, Type 1 Diabetes, Asthma, Chronic peptic ulcers, Tuberculosis, Hepatitis, Chronic active hepatitis, Celiac Disease (gluten sensitive enteropathy), Addison Disease, Crohn’s disease, Graves’ Disease, Pernicious and Aplastic Anemia, Sjogren Syndrome, Irritable Bowel Syndrome (IBS), Multiple Sclerosis, Rheumatoid arthritis, Chronic periodontitis, Ulcerative colitis, Chronic sinusitis, Myasthenia Gravis, Atherosclerosis, Vasculitis, Dermatitis, Diverticulitis, Rheumatoid Arthritis, Reactive Arthritis, Alopecia Areata, Psoriasis, Scleroderma, Fibromyalgia, Chronic Fatigue Syndrome and Vitiligo; aging related diseases like cardiovascular disease, arthritis, cancer, Alzheimer’s disease, dementia, cataracts, osteoporosis, diabetes, hypertension, glaucoma, hearing loss, Parkinson’s Disease, Huntington’s Disease, Prion Disease, Motor Neurone Disease, Spinocerebellar Ataxia, Spinal muscular atrophy, Amyotrophic lateral sclerosis, Friedreich’s Ataxia, Lewy Body Disease, chronic infections and much more.